Chemoinformaics analysis of Houttuynoside A (2)
| Molecular Weight | 450.396 | nRot | 6 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 20 |
| Exact Molecular Weight | 450.116 | nRing | 3 |
| Solubility: LogS | -3.12 | nHRing | 1 |
| Solubility: LogP | 1.448 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 58.5614 |
| nHD | 5 | BPOL | 30.7506 |
| QED | 0.373 |
| Synth | 3.562 |
| Natural Product Likeliness | 1.347 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.035 |
| HIA | 0.908 |
| CACO-2 | -6.225 |
| MDCK | 0.0000352 |
| BBB | 0.724 |
| PPB | 0.942643 |
| VDSS | 0.386 |
| FU | 0.0735302 |
| CYP1A2-inh | 0.09 |
| CYP1A2-sub | 0.048 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.764 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.253 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.052 |
| CL | 10.707 |
| T12 | 0.865 |
| hERG | 0.067 |
| Ames | 0.042 |
| ROA | 0.009 |
| SkinSen | 0.033 |
| Carcinogencity | 0.174 |
| EI | 0.032 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.269 |
| Antiviral | Yes |
| Prediction | 0.747714 |